Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Follow-Up Questions
Galderma Group AG 的 CEO 是谁？
Dr. Flemming Ornskov 是 Galderma Group AG 的 Chief Executive Officer，自 2019 加入公司。
GALDY 股票的价格表现如何？
GALDY 的当前价格为 $35.15，在上个交易日 decreased 了 0%。
Galderma Group AG 的主要业务主题或行业是什么？
Galderma Group AG 属于 Pharmaceuticals 行业，该板块是 Health Care
Galderma Group AG 的市值是多少？
Galderma Group AG 的当前市值是 $41.2B
Galderma Group AG 是买入、卖出还是持有？
据华尔街分析师称，共有 16 位分析师对 Galderma Group AG 进行了分析师评级，包括 6 位强烈买入，9 位买入，4 位持有，0 位卖出，以及 6 位强烈卖出
